MORNEAU MICHAEL 4
4 · Viking Therapeutics, Inc. · Filed May 31, 2018
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Sale
Common Stock, par value $0.00001 per share
2018-05-31$9.25/sh−21,551$199,347→ 94,035 total
Footnotes (1)
- [F1]All 21,551 of the shares were acquired on May 18, 2018 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.